Randomized, Double-blind Placebo-controlled Phase I Study to Assess Safety, Tolerance and Pharmacokinetics of a Single Intravenous Injection Kukoamine B Mesilate in Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 05 May 2017
Price : $35 *
At a glance
- Drugs Kukoamine B (Primary)
- Indications Sepsis
- Focus Adverse reactions
- Sponsors Tianjin Chase Sun Pharmaceutical
- 03 Feb 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 04 Nov 2015 Planned primary completion date changed from 1 Aug 2015 to 1 Dec 2015, according to the ClinicalTrials.gov record.
- 04 Nov 2015 Status changed from recruiting to active, no longer recruiting, according to the ClinicalTrials.gov record.